ZEISS Medical Technology announced that China's National Medical Products Administration (NMPA) has approved the ZEISS ARTEVO 750 and ARTEVO 850 ophthalmic microscopes. The microscopes provide high quality optical and digital visualization for both anterior and posterior segments. With upgrades spanning both hardware and software, the newly approved microscopes supporting ophthalmic surgeries ensure more precise operations and greater surgical safety with enhanced resolution, RGB illumination and full compatibility with the latest generation of ZEISS's cataract workflow.
The ZEISS ARTEVO750 ophthalmic microscope is another breakthrough in ZEISS's ophthalmic surgical microscope family that made its Chinese debut at the 2025 China International Import Expo (CIIE). Combining advanced technology with established optical expertise, the ARTEVO 750 enables surgeons to finetune their surgical views in routine and complex procedures, including cataract & vitreoretinal surgery, corneal transplantation, and minimally invasive glaucoma surgery (MIGS). With enhanced resolution, elevated depth of field, intelligent RGB illumination and intraoperative OCT, the ZEISS ARTEV 750 supports excellent usability and a seamless end-to-end workflow.
The availability in China of the next generation of ZEISS ophthalmic microscopes, including the ZEISS ARTEvo 750 and ARTEVO 850, helps transform the surgical experience with superior optics and capabilities. The ZEISS ARteVO 850 will be showcased as part of ZEISS's ophthal Micmic workflows in the ZEISS booth #5FG-J01 at the 41 Asia-Pacific Academy of Ophthalmology (APAO) conference in Hong Kong from February 5-8, 2026.
